Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

University of Manitoba

$757,350.00

The impact of epithelial cell derived semaphorin3E on airway remodeling in allergic asthma

FY 2019-20

Summary
Asthma is a chronic disease of the lungs, in which patients struggle to breathe due to excessive narrowing of the airways and mucus production. According to the World Health Organization, asthma is a serious public health problem affecting over 300 million patients and their families worldwide. Asthma takes the lives of approximately five hundred Canadians each year. Researchers seek to understand not only how and why a person develops asthma but also the disease process itself, because "knowing your enemy" can lead to the development of new therapies to treat asthma. In our lab, we are looking at a molecule called Sema3E, because it appears to send signals that protect against many of the debilitating effects of asthma. Interestingly, patients with severe asthma have less Sema3E in their airways compared to people who don't have asthma. We can mimic asthma in mice, and these mice have shown us that disrupting the normal function of Sema3E makes the disease worse. In this project, we will focus on better understanding why this happens. This knowledge will point to new ways to potentially lessen or even reverse the effects of this terrible disease.
Program
Project Grant
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
421123
Name
Soussi Gounni Abdelilah
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Respiratory System
Projecttitle
The impact of epithelial cell derived semaphorin3E on airway remodeling in allergic asthma
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$757,350
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Airway Hyprresponsiveness; Asthma; Epithelial Cells; Plexind1; Regulation; Remodeling; Semaphorin3e
Abstract
Asthma is a chronic disease of the lungs, in which patients struggle to breathe due to excessive narrowing of the airways and mucus production. According to the World Health Organization, asthma is a serious public health problem affecting over 300 million patients and their families worldwide. Asthma takes the lives of approximately five hundred Canadians each year. Researchers seek to understand not only how and why a person develops asthma but also the disease process itself, because "knowing your enemy" can lead to the development of new therapies to treat asthma. In our lab, we are looking at a molecule called Sema3E, because it appears to send signals that protect against many of the debilitating effects of asthma. Interestingly, patients with severe asthma have less Sema3E in their airways compared to people who don't have asthma. We can mimic asthma in mice, and these mice have shown us that disrupting the normal function of Sema3E makes the disease worse. In this project, we will focus on better understanding why this happens. This knowledge will point to new ways to potentially lessen or even reverse the effects of this terrible disease.
Competitiondate
202003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Soussi Gounni, Abdelilah
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $757,350~ $0~
University of Manitoba - $757,350 Grant (2019-20) | Canada Spends